The global increase in HCC associated with MASLD is driven by the increase in metabolic diseases [48], with confirmed risk factors including T2D, obesity, and the patatin-like phospholipase domain-containing 3 (PNPLA3) gene variant [49]. The gene discussed is PNPLA3; the disease is type 2 diabetes mellitus.